Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...

A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer. Read more ...

Veracyte, Inc. , a leading cancer diagnostics company, today announced new data that reinforce the ability of its Decipher Bladder Genomic Subtyping Classifier to help improve staging for patients ...

Figure 1 The metastatic cascade in prostate cancer and molecular effects of radiotherapy ... disease are a heterogeneous subgroup of patients and urgently need a better stratification system to ...

A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...

A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.

A new UCSF study shows a significant increase in advanced prostate cancer cases in California, growing faster than the ...

The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study by UC San Francisco.

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Prostate cancer is a significant health issue in India, with 37,000 new cases and 18,000 deaths annually. AI is ...